Loading organizations...
§ Private Profile · Palo Alto, CA, USA
Ultrasensitive non-invasive liquid biopsy tests for cancer detection.
Lucence Diagnostics has raised $20.0M across 1 funding round.
Lucence Diagnostics has raised $20.0M in total across 1 funding round.
Lucence Diagnostics has raised $20.0M across 1 funding round. Most recently, it raised $20.0M Series A in November 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 19, 2019 | $20M Series A | Kelvin LOH | Boon Hwee KOH, LIM Kaling, Heliconia Capital, Sginnovate | Announced |
Lucence Diagnostics has raised $20.0M in total across 1 funding round.
Lucence Diagnostics's investors include Kelvin Loh, Boon Hwee Koh, Lim Kaling, Heliconia Capital, SGInnovate.